Central Virginia

Central Virginia nonprofits can apply for grants to support community health initiatives through a partnership between the Charlottesville Area Community Foundation and the University of Virginia Health System.

Local biotechnology industry leader Nikki Hastings, PhD, has been named the first Executive Director of the CvilleBioHub, a non-profit that connects and supports the Charlottesville-area biotechnology sector.  CvilleBioHub will receive strategic pla

The UVA Licensing & Ventures Group helps discoveries reach their full potential in the marketplace. In 2018 there were 213 invention disclosures filed, 59 U.S. patents issued and 77 transactions with commercial partners. 

UVA Professor Shawn Russell helps those with disabilities take on skiing, proving that biomechanics research has real-life applications that can change lives for the better in Virginia and beyond.

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

UVA's Center for Transportation Studies hired its first Safety Circuit Rider Engineer to fully deploy its Safety Circuit Rider Program.

The CvilleBioHub invites the biotechnology community to a reception with next generation scientists enrolled in UVA's Biotechnology Training Program.